Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.7912
-0.0062 (-0.78%)
At close: Mar 16, 2026, 4:00 PM EDT
0.7820
-0.0092 (-1.16%)
After-hours: Mar 16, 2026, 7:39 PM EDT

Evogene Revenue

In the year 2025, Evogene had annual revenue of $3.85M, down -54.73%. Evogene had revenue of $314.00K in the quarter ending December 31, 2025, a decrease of -79.65%.

Revenue (ttm)
$3.95M
Revenue Growth
-51.39%
P/S Ratio
1.79
Revenue / Employee
$32,932
Employees
117
Market Cap
6.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.85M-4.66M-54.73%
Dec 31, 20248.51M2.87M50.90%
Dec 31, 20235.64M3.97M236.72%
Dec 31, 20221.68M745.00K80.11%
Dec 31, 2021930.00K-110.00K-10.58%
Dec 31, 20201.04M287.00K38.11%
Dec 31, 2019753.00K-994.00K-56.90%
Dec 31, 20181.75M-1.63M-48.33%
Dec 31, 20173.38M-3.16M-48.30%
Dec 31, 20166.54M-4.59M-41.23%
Dec 31, 201511.13M-3.38M-23.31%
Dec 31, 201414.51M-3.07M-17.46%
Dec 31, 201317.58M509.00K2.98%
Dec 31, 201217.07M2.17M14.57%
Dec 31, 201114.90M2.34M18.61%
Dec 31, 201012.56M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition